Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 225

The DOI matches its Crossref record.

Oral Contraceptives and the Risk of Myocardial Infarction

Open access
Tanis, Bea C., van den Bosch, Maurice A. A. J., Kemmeren, Jeanet M., Cats, Volkert Manger, Helmerhorst, Frans M., Algra, Ale, van der Graaf, Yolanda, Rosendaal, Frits R. · 2002 · Obstetrical and Gynecological Survey

Abstract

Back-groundAn association between the use of oral contraceptives and the risk of myocardial infarction has been found in some, but not all, studies.We investigated this association, according to the type of progestagen included in third-generation (i.e., desogestrel or gestodene) and second-generation (i.e., levonorgestrel) oral contraceptives, the dose of estrogen, and the presence or absence of prothrombotic mutations.Methods In a nationwide, population-based, casecontrol study, we identified and enrolled 248 women 18 through 49 years of age who had had a first myocardial infarction between 1990 and 1995 and 925 control women who had not had a myocardial infarction and who were matched for age, calendar year of the index event, and area of residence.Subjects supplied Information on oral-contraceptive use and major cardiovascular risk factors.An analysis for factor V Leiden and the G20210A mutation in the prothrombin gene was conducted in 217 patients and 763 controls. ResultsThe odds ratio for myocardial infarction among women who used any type of combined oral contraceptive, äs compared with nonusers, was 2.0 (95 percent confidence interval, 1.5 to 2.8).The adjusted odds ratio was 2.5 (95 percent confidence interval, 1.5 to 4.1) among women who used second-generation oral contraceptives and 1.3 (95 percent confidence interval, 0.7 to 2.5) among those who used third-generation oral contraceptives.Among women who used oral contraceptives, the odds ratio was 2.1 (95 percent confidence interval, 1.5 to 3.0) for those without a prothrombotic mutation and 1.9 (95 percent confidence interval, 0.6 to 5.5) for those with a mutation. ConclusionsThe risk of myocardial infarction was increased among women who used second-generation oral contraceptives.The results with respect to the use of third-generation oral contraceptives were inconclusive but suggested that the risk was Iower than the risk associated with second-generation oral contraceptives.The risk of myocardial infarction was similar among women who used oral contraceptives whether or not they had a prothrombotic mutation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00006254-200205000-00021

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 225

Metadata

Authors
Tanis, B. C., van den Bosch, M. A. A. J., Kemmeren, J. M., Cats, V. M., Helmerhorst, F. M., Algra, A., van der Graaf, Y., & Rosendaal, F. R.
Venue
Obstetrical and Gynecological Survey
Published
2002-05
Volume
57
Issue
5
Pages
297-298
ISSN
0029-7828 (ISSN-L)
OpenAlex
W2328300666
Cited by
225
References
0
FWCI
12.46
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Oral Contraceptives and the Risk of Myocardial Infarction. https://app.cochat.ai/papers/10.1097/00006254-200205000-00021
The paper
Tanis, B. C., van den Bosch, M. A. A. J., Kemmeren, J. M., Cats, V. M., Helmerhorst, F. M., Algra, A., van der Graaf, Y., & Rosendaal, F. R. (2002). Oral Contraceptives and the Risk of Myocardial Infarction. Obstetrical and Gynecological Survey. https://doi.org/10.1097/00006254-200205000-00021

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.